Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration
about
Anti-VEGF Therapy and the Retina: An UpdateRetinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of interventionEmerging therapies for neovascular age-related macular degeneration: state of the artEfficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage.Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cellsDiabetic macular edema: classification, medical and laser therapy.Current and future pharmacological intervention for diabetic retinopathy.A review of drug options in age-related macular degeneration therapy and potential new agents.Current treatment approaches in diabetic macular edema.Diabetic retinopathy: current management and experimental therapeutic targets.Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Intraocular pressure after intravitreal injection of triamcinolone acetonide.Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Pathomechanisms of cystoid macular edema.'What controls aqueous humour outflow resistance?'.Intravitreal triamcinolone acetonide: a change in a paradigm.Promising new treatments for neovascular age-related macular degeneration.Retinal sensitivity improvement after intravitreal triamcinolone acetonide injection for macular edema secondary to branch retinal vein occlusion.Ranibizumab in neovascular age-related macular degeneration.The use of intraocular corticosteroids.The dexamethasone drug delivery system: indications and evidence.Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema.Intraocular corticosteroids for posterior segment disease: 2012 update.Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cellsIntravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema.Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion.Intravitreal triamcinolone in recurrence of choroidal neovascularisation.Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration.Transendothelial electrical resistance of bovine retinal capillary endothelial cells is influenced by cell growth patterns: an ultrastructural study.Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.Expression of cytokines on the iris of patients with neovascular glaucoma.
P2860
Q26784605-2A3A4B6D-CA2B-4FCE-9478-89D33027D211Q28076321-B54091A1-8027-42D0-9A63-1B14070F47CAQ28253918-52C72237-312A-4113-950B-5CEE91D847D2Q30491121-AD0DCA19-1010-49CD-BFD9-D7E0DDA33022Q30833907-C2896C05-8D85-4431-BD4A-5DF0BEAB8740Q33203899-083ED6EA-6EB8-416D-B817-1E61C5AB9B6DQ33208471-7441C45A-9905-414A-950A-9C259B34FAD9Q33216425-CB08E27F-7992-43AC-81EB-48F51C24B9E0Q33263803-D0F972BB-699C-43DE-BE58-87A36BA96855Q33279749-8A719243-49A3-4D33-BED4-D133CE155CC7Q33403016-311DD9EE-8CDC-467A-A191-0316E20BC469Q35030923-5CFBAFEE-F04C-4795-AE9B-644A8558B2F9Q35590421-D49425A7-5978-4146-85A8-583739A95AC7Q35590749-C62010EE-75F9-46F9-91A1-78AE2C4F010AQ35975532-F62D8DE3-BC19-4822-B272-355B576EE180Q36357303-2EDDC9B2-5477-49C5-92D6-2AD0F7ECCF45Q36500994-237CCAD2-5D46-4ACE-82BD-2ED870E9D4C6Q36512564-0C66EA1F-BFDD-4B1F-AB52-C0E550A74769Q36562300-3508EED7-6F39-4E54-9459-9F60390135DFQ37018974-D45BA0D9-E9F9-4B17-B701-C92755177175Q37598893-7398656D-19B2-4177-9FF0-02A6F2106163Q37865422-3906EE21-7634-4B42-B178-EA973D0E2697Q37905833-67B60754-16CB-4178-94B9-ED9912669672Q38025444-C8EF0A20-AEDF-443C-AC7B-CD854F5E13B1Q41194130-6C977DA8-B374-47B7-B8BD-882EE3AC4EACQ41859736-3F657DFA-2041-43B1-8448-BB637949D120Q43008185-5399B47A-BB63-4078-B0D2-9A4A4AFC0A64Q43009470-066269F0-5F37-4561-8D3D-14CDA6A8745CQ43668999-79436D49-19EB-4E36-B22B-A9F829C739EDQ44525352-56363869-0439-4211-85A2-53191E37A79CQ45823132-0D3902C1-B3F0-4377-B261-8F957A2561A8Q54198332-67A81040-B9D4-4FB0-A403-8F9B06F1333A
P2860
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Triamcinolone acetonide modula ...... tions for macular degeneration
@ast
Triamcinolone acetonide modula ...... tions for macular degeneration
@en
Triamcinolone acetonide modula ...... tions for macular degeneration
@nl
type
label
Triamcinolone acetonide modula ...... tions for macular degeneration
@ast
Triamcinolone acetonide modula ...... tions for macular degeneration
@en
Triamcinolone acetonide modula ...... tions for macular degeneration
@nl
prefLabel
Triamcinolone acetonide modula ...... tions for macular degeneration
@ast
Triamcinolone acetonide modula ...... tions for macular degeneration
@en
Triamcinolone acetonide modula ...... tions for macular degeneration
@nl
P2093
P2860
P1476
Triamcinolone acetonide modula ...... tions for macular degeneration
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2000.01316.X
P577
2000-09-01T00:00:00Z